Literature DB >> 10524257

Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1.

S M Lee1, H Y Li, E K Ng, S M Or, K K Chan, M Kotaka, S S Chim, S K Tsui, M M Waye, K P Fung, C Y Lee.   

Abstract

We have amplified and sequenced a novel, alternatively spliced variant of a human gene coding for the four-and-a-half LIM domain protein 1 (FHL1). This gene is located at chromosome Xq27 and the spliced variant is named FHL1B. The ORF of FHL1B cDNA codes for a LIM-only protein that possesses a zinc finger and three tandem repeats of LIM domains at the N-terminus with an active bipartite nuclear localization signal (NLS) motif and a possible RBP-J binding region at the C-terminus. FHL1B and FHL1 have the same N-terminal three-and-a-half LIM domains but different C-terminal protein sequences, due to the presence of an additional alternative exon 4b in FHL1B causing a frame-shift in the 3'coding region. RT-PCR results revealed that the expression of FHL1 is not restricted in skeletal muscle and heart, but is widely distributed in other tissues, including brain, placenta, lung, liver, kidney and pancreas, albeit as a low abundance transcript. In contrast, FHL1B is specifically expressed in brain. The C-terminal alternative region in FHL1B is sufficient to localize FHL1B in the nucleus of mammalian cell. FHL1B is probably related to neural differentiation and certain fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524257     DOI: 10.1016/s0378-1119(99)00251-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing.

Authors:  M Brudno; M S Gelfand; S Spengler; M Zorn; I Dubchak; J G Conboy
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

2.  Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.

Authors:  Elizabeth Vafiadaki; Demetrios A Arvanitis; Vasiliki Papalouka; Gerasimos Terzis; Theodoros I Roumeliotis; Konstantinos Spengos; Spiros D Garbis; Panagiota Manta; Evangelia G Kranias; Despina Sanoudou
Journal:  FEBS J       Date:  2014-06-11       Impact factor: 5.542

Review 3.  An emerging link between LIM domain proteins and nuclear receptors.

Authors:  Stefano Sala; Christophe Ampe
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

4.  Fhl1 W122S causes loss of protein function and late-onset mild myopathy.

Authors:  Valentina Emmanuele; Akatsuki Kubota; Beatriz Garcia-Diaz; Caterina Garone; Hasan O Akman; Daniel Sánchez-Gutiérrez; Luis M Escudero; Shingo Kariya; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

5.  Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis.

Authors:  Katsuya Sato; Masashi Kimura; Kazue Sugiyama; Masashi Nishikawa; Yukio Okano; Hitoshi Nagaoka; Takahiro Nagase; Yukio Kitade; Hiroshi Ueda
Journal:  J Biol Chem       Date:  2016-10-20       Impact factor: 5.157

6.  A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM.

Authors:  G M Fimia; D De Cesare; P Sassone-Corsi
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

8.  Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.

Authors:  Ruben Pio; David Blanco; Maria Jose Pajares; Elena Aibar; Olga Durany; Teresa Ezponda; Jackeline Agorreta; Javier Gomez-Roman; Miguel Angel Anton; Angel Rubio; Maria D Lozano; Jose M López-Picazo; Francesc Subirada; Tamara Maes; Luis M Montuenga
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

9.  Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.

Authors:  Lucie Gueneau; Anne T Bertrand; Jean-Philippe Jais; Mustafa A Salih; Tanya Stojkovic; Manfred Wehnert; Maria Hoeltzenbein; Simone Spuler; Shinji Saitoh; Annie Verschueren; Christine Tranchant; Maud Beuvin; Emmanuelle Lacene; Norma B Romero; Simon Heath; Diana Zelenika; Thomas Voit; Bruno Eymard; Rabah Ben Yaou; Gisèle Bonne
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

10.  Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.

Authors:  Edoardo Malfatti; Montse Olivé; Ana Lía Taratuto; Pascale Richard; Guy Brochier; Marc Bitoun; Lucie Gueneau; Pascal Laforêt; Tanya Stojkovic; Thierry Maisonobe; Soledad Monges; Fabiana Lubieniecki; Gabriel Vasquez; Nathalie Streichenberger; Emmanuelle Lacène; Maria Saccoliti; Bernard Prudhon; Marilena Alexianu; Dominique Figarella-Branger; Joachim Schessl; Carsten Bonnemann; Bruno Eymard; Michel Fardeau; Gisèle Bonne; Norma Beatriz Romero
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.